Next report date
Report period
Q2 2024
EPS estimate
−0.26USD
Revenue estimate
—
−0.92USD
−85.90 MUSD
100.51 M
About VIKING THERAPEUTICS INC COM USD0.00001
Sector
CEO
Brian Lian
Headquarters
San Diego
Website
Employees (FY)
27
Founded
2012
FIGI
BBG00LJZ4457
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0VQA is 67.34 USD — it has increased by 2.24% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange VIKING THERAPEUTICS INC COM USD0.00001 stocks are traded under the ticker 0VQA.
VIKING THERAPEUTICS INC COM USD0.00001 is going to release the next earnings report on Jul 24, 2024. Keep track of upcoming events with our Earnings Calendar.
0VQA stock is 9.96% volatile and has beta coefficient of 2.83. Check out the list of the most volatile stocks — is VIKING THERAPEUTICS INC COM USD0.00001 there?
0VQA earnings for the last quarter are −0.25 USD per share, whereas the estimation was −0.25 USD resulting in a 1.59% surprise. The estimated earnings for the next quarter are −0.28 USD per share. See more details about VIKING THERAPEUTICS INC COM USD0.00001 earnings.
Yes, you can track VIKING THERAPEUTICS INC COM USD0.00001 financials in yearly and quarterly reports right on TradingView.
0VQA stock has risen by 3.32% compared to the previous week, the month change is a 3.81% fall, over the last year VIKING THERAPEUTICS INC COM USD0.00001 has showed a 230.80% increase.
0VQA net income for the last quarter is −27.36 M USD, while the quarter before that showed −24.61 M USD of net income which accounts for −11.18% change. Track more VIKING THERAPEUTICS INC COM USD0.00001 financial stats to get the full picture.
Today VIKING THERAPEUTICS INC COM USD0.00001 has the market capitalization of 7.12 B, it has decreased by 6.03% over the last week.
No, 0VQA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0VQA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIKING THERAPEUTICS INC COM USD0.00001 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 27.00 employees. See our rating of the largest employees — is VIKING THERAPEUTICS INC COM USD0.00001 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VIKING THERAPEUTICS INC COM USD0.00001 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VIKING THERAPEUTICS INC COM USD0.00001 stock shows the buy signal. See more of VIKING THERAPEUTICS INC COM USD0.00001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on VIKING THERAPEUTICS INC COM USD0.00001 future price: according to them, 0VQA price has a max estimate of 138.00 USD and a min estimate of 90.00 USD. Read a more detailed VIKING THERAPEUTICS INC COM USD0.00001 forecast: see what analysts think of VIKING THERAPEUTICS INC COM USD0.00001 and suggest that you do with its stocks.